Lipid lowering: the evidence, the guidelines, the clinical reality
EPCCS 2018 Despite the known efficacy of lipid-lowering therapy, in clinical reality still many patients remain at high risk, for instance due to statin intolerance. The panel discusses how to manage this, and also which risk assessment tools can be used in which patients, to guide treatment decisions.
Educational Information
This video was recorded during the two-day EPCCS CV Summit and aims to give an impression of the presentation given by prof. Visseren.
Faculty
Prof. Frank Visseren - internist, UMC Utrecht, the Netherlands
Dr. Monika Hollander - General Practitioner, Julius Center for Health Sciences and Primary Care, Utrecht, The Netherlands
Dr. Jan Oltrogge - General Practitioner, Hamburg, Germany
Disclosures
This recording was independently developed under auspices of EPCCS. The views expressed in this recording are those of the individual presenters and do not necessarily reflect the views of EPCCS. No funding was obtained for the recording of this video.
Chapters
Join us
Join the Global Primary Care Cardio Network. Membership is free.
Would you like to tell us more about yourself?
Interests
We will send you an email with a link to confirm your registration.
